UMIN-CTR History

BACK TOP
UMIN-CTR English Home Glossary (Simple) FAQ Search clinical trials

Name:
UMIN ID:

Unique ID issued by UMIN UMIN000011914
Receipt No. R000013914
Scientific Title A Phased Desensitization Protocol With Rituximab and Bortezomib for Highly HLA-sensitized Transplant Patients.
Date of disclosure of the study information 2013/09/30
Last modified on 2020/05/18 18:40:25

No. Disposal Last modified on Item of update
1 Insert 2013/09/30 18:10:44
2 Update 2018/05/17 20:29:34 Name of primary sponsor
Organization
3 Update 2018/06/12 21:17:24 UMIN ID1
4 Update 2019/02/12 14:53:53 Public title
Public title
Acronym
Acronym
5 Update 2019/02/12 14:58:15 Condition
Condition
Narrative objectives1
Narrative objectives1
Primary outcomes
Primary outcomes
6 Update 2019/02/12 15:16:21 Study type
Basic design
Randomization
Blinding
Control
No. of arms
Purpose of intervention
Type of intervention
Interventions/Control_1
Interventions/Control_1






Key inclusion criteria
Key inclusion criteria
Key exclusion criteria
Key exclusion criteria
Target sample size
7 Update 2019/02/12 15:25:58 Organization
Organization
Organization1
Tel1
Email1
8 Update 2019/02/12 15:47:46 Interventions/Control_1
Key inclusion criteria
Key inclusion criteria
Key exclusion criteria
Key exclusion criteria
9 Update 2020/05/18 18:40:25 Recruitment status
Date of IRB
Last follow-up date


Contact us.